Dawei Ding

Associate Professor

Calculated based on number of publications stored in Pure and citations from Scopus
20092024

Research activity per year

Personal profile

Personal profile

Dr. Ding has an interdisciplinary education background from biotechnology to pharmaceutics, and biomaterials science and engineering. His research focuses on the development of biocompatible carrier-based nanomedicines, transdermal drug delivery systems and microfluidics-based technologies for multimodal treatments (e.g., chemotherapy, phototherapy and immunotherapy) of various diseases including cancers and inflammations. Dr. Ding has published nearly 30 SCI papers, including 17 of them with him as the (co-)corresponding/first author in top journals such as Adv. Mater., ACS Nano, Biomaterials, Chem. Eng. J., Nano Lett., and J. Control. Release. He also published one chapter of an international book regarding microfluidics. He has been granted 5 invention patents by the United States, China, Japan and the Europe, and has won several awards including the Patent Excellence Award of China (2020) and Science and Technology Progress Award of Taizhou City ( First Prize) (2015). Dr. Ding warmly welcomes students interested in the research of biomaterials, drug delivery systems and microfluidics to join the lab. He also welcomes enterprises that have needs in the design and improvement of formulations to cooperate, including the development and application of traditional formulations (controlled-release microspheres, hydrogels, etc.) as well as nanomedicines, and transdermal formulations such as microneedles.

Experience

2024-present, Associate Professor, Academy of Pharmacy, XJTLU, Suzhou, China

2019-2024, Professor, College of Pharmaceutical Sciences, Soochow University, Suzhou, China

2016-2019, Postdoctoral Associate, Singapore-MIT Alliance for Research and Technology (SMART), Singapore

2015-2016, Project Officer/Research Fellow, School of Materials Science and Engineering, Nanyang Technological University, Singapore

Research interests

(1) Synergistic tumor treatment via biocompatible nanomedicines (Chemical therapy, phototherapy, immunotherapy etc.)

(2) Transdermal drug delivery systems (Patches, microneedles etc.)

(3) Oral and topical drug delivery systems (Sustained-release microparticles etc.)

(4) Microfluidics and their applications in biomedicine

Awards and honours

(1) Patent Excellence Award of China (2020)

(2) The Science and Technology Progress Award of Taizhou City (First Prize) (2015)

(3) Best Poster Award, 6th Materials Research Society-Singapore Conference on Advanced Materials (2014)

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 7 - Affordable and Clean Energy

Related documents

Education/Academic qualification

PhD, Nanyang Technological University

1 Aug 201131 Jul 2015

Master, Nanjing University

1 Sept 200820 Jun 2011

Bachelor, Nanjing University

1 Sept 200420 Jun 2008

Keywords

  • RS Pharmacy and materia medica
  • Drug delivery system
  • Nanomedicine
  • Transdermal drug delivery
  • Tumor treatment
  • Microfluidics

Person Types

  • Staff

Fingerprint

Dive into the research topics where Dawei Ding is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or